| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $454K | +304.1% |
| SG&A Expense | $648K | -44.5% |
| Operating Income | -$1.8M | +17.1% |
| Pre-tax Income | -$2.1M | +10.8% |
| Net Income | -$2.1M | +10.3% |
| EPS (Basic) | -$0.02 | +0.0% |
| EPS (Diluted) | -$0.02 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $513K | +9862.5% |
| Total Assets | $659K | +374.8% |
| Current Liabilities | $3.2M | +68.3% |
| Total Liabilities | $3.2M | +68.3% |
| Stockholders' Equity | -$2.6M | -44.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$526K | -844.5% |
| Investing Cash Flow | -$23K | +18.1% |
| Financing Cash Flow | $1.1M | +1573.5% |